LAMB4

Across TCGA pan-cancer cohorts, LAMB4 Mutation is linked to patient survival in 8 of 34 cancer types, making it a survival-associated LAMB4 data layer compared with 27 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher LAMB4 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated LAMB4 expression acts as an unfavorable survival marker, although some lineages such as UCEC and SKCM show a favorable association.

UCEC, KICH, and SARC are the cancer types where LAMB4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	II,III,IV	0.945	0.427	.005	34	view →
KICH	DFS	Median	All	0.102	0.848	.004	13	view →
SARC	OS	Median	All	0.189	0.747	<.001	12	view →
PAAD	DFS	Median	All	0.006	0.505	<.001	6	view →
LUSC	DFS	Median	III,IV	0.079	0.751	.024	6	view →
BRCA	DFS	Median	All	0.198	0.527	.020	4	view →
SKCM	OS	Median	All	0.800	0.329	.001	4	view →
ACC	DFS	Median	All	0.195	0.748	.003	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

LAMB4–UCEC (DFS)

Open the UCEC breakdown →